Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/24 16:31 | 5/29/24 | VCNX | Health | Drug | Pharmaceutical Preparations | Friedberg Albert | A6 | DT | P.dm | 9 | 5.07 | 0 | 2 | 0 | 581 | I | |||||||||||||||
4/22/24 16:33 | 4/19/24 | VCNX | Health | Drug | Pharmaceutical Preparations | Friedberg Albert | A6 | DT | P.d | 1 | 4.73 | 0 | 0 | 0 | 580 | I | |||||||||||||||
10/5/23 16:31 | 10/3/23 | VCNX | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DOT | P,CEO | P.dm | 510 | 0.9990 | 0 | 510 | 96 | 1,042 | M | ||||||||||||||
10/5/23 16:30 | 10/3/23 | VCNX | Health | Drug | Pharmaceutical Preparations | Friedberg Albert | A6 | DT | P.d | 3,000 | 1.00 | 0 | 3,000 | 149 | 5,014 | I | |||||||||||||||
2/24/22 16:37 | 2/23/22 | VCNX | Health | Drug | Pharmaceutical Preparations | Van Strydonck, Gerald E. | NY | D | P.d | 26 | 1.32 | 0 | 20 | New | 20 | D | |||||||||||||||
1/31/22 16:26 | 1/27/22 | VCNX | Health | Drug | Pharmaceutical Preparations | Frieberg Jacob B. | NY | D | P.d | 100 | 1.11 | 0 | 90 | 125 | 162 | I | |||||||||||||||
1/31/22 16:24 | 1/27/22 | VCNX | Health | Drug | Pharmaceutical Preparations | Friedberg Albert | A6 | DT | P | 4,000 | 1.11 | 0 | 3,604 | 30 | 15,570 | I | |||||||||||||||
1/31/22 16:23 | 1/27/22 | VCNX | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DO | P,CEO | P.d | 2,000 | 1.11 | 0 | 1,802 | 106 | 3,503 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |